clinical symptom
[대역어] None
[용어속성] Term
[용어속성] Term
Clinical course of novel COVID-19 infection in pregnant women
Observational Study
Published on
Journal: The journal of maternal-fetal & neonatal medicine
[Category] COVID19(2023년), SARS, 임상, 치료기술,
Journal: The journal of maternal-fetal & neonatal medicine
[Category] COVID19(2023년), SARS, 임상, 치료기술,
[키워드] alanine aminotransferase
analyzed
Anemia
Anosmia
antimicrobial
APGAR score
Asymptomatic
C-reactive protein
carbapenem
change
clinical
Clinical course
clinical symptom
contribute
coronavirus
cough
Course
COVID-19
COVID-19 infection
CPAP therapy
creatinine
CRP
decrease
demographic
disease
drug
Elimination
epidemiological
erythrocyte
excluded
form
Immunity
increase in
Infection
interferon
Laboratory
lactate dehydrogenase
LDH
leukopenia
low molecular weight
lymphocyte
manifestation
maternal and perinatal outcomes.
mechanical ventilation
Mild
moderate
morbidity
Neonatal
Neonatal COVID-19
Neonate
no evidence of
occurred
outcome
outcomes
Oxygenation
PCR
polymerase chain
predictor
Pregnancy
pregnant women
preterm delivery
prospective observational study
recommendations
reported
required
SARS-CoV-2
Severe case
severe COVID-19
Spontaneous
Transmission
virus
women
[DOI] 10.1080/14767058.2020.1850683 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1080/14767058.2020.1850683 PMC 바로가기 [Article Type] Observational Study
SARS-CoV-2 reinfection and COVID-19 severity
SARS-CoV-2 재감염 및 COVID-19 심각성
Article
[키워드] antibodies
antibody
clinical recovery
clinical symptom
Clinical symptoms
coronavirus
COVID-19
COVID-19 severity
diagnosed
early stage
episode of
Frequency
Hospitalization
ICU
Infection
infections
negative RT-PCR
no difference
no differences
Patient
patients
patients with SARS-CoV-2
performed
positive
positive RT-PCR
Reinfection
RT-PCR
SARS-CoV-2
SARS-CoV-2 positive RT-PCR
serology
Seven
severity
Severity of infection
Severity.
transfer
variant
was performed
were infected
Whole genome sequencing
[DOI] 10.1080/22221751.2022.2052358 PMC 바로가기 [Article Type] Article
[DOI] 10.1080/22221751.2022.2052358 PMC 바로가기 [Article Type] Article
Association of trace element status in COVID-19 patients with disease severity
Research article
Published on
Journal: Journal of trace elements in medicine and biology
[Category] COVID19(2023년), SARS, 변종,
Journal: Journal of trace elements in medicine and biology
[Category] COVID19(2023년), SARS, 변종,
[키워드] Anti-inflammatory
antioxidant
clinical condition
clinical symptom
conditions
coronavirus
coronavirus disease
COVID-19
COVID-19 patient
COVID-19 severity
Critical
Cu
death
died
disease severity
evaluated
Fe
four group
groups
I
immune response
immune system
Infection
Mg
Mild symptom
new SARS-CoV-2
no difference
Patient
reduce
risk
SARS-COV-2 infection
Se
Serum level
severity
severity of symptoms
shown
significant difference
the patient
Trace element
trace elements
Zn
[DOI] 10.1016/j.jtemb.2022.127055 [Article Type] Research article
[DOI] 10.1016/j.jtemb.2022.127055 [Article Type] Research article
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents
Article
[키워드] anti-CD20
anti-CD20 therapy
Anti-spike
anti-Spike IgG
antibody
antibody kinetics
B-cell
clinical care
clinical status
clinical symptom
Complete
contribute
convalescent
convalescent plasma
COVID-19 patient
Decline
donors
eligible
evaluated
Follow-up
hospitalized COVID-19 patients
humoral
Humoral immunity
IgG
Immune escape
Immunocompromised
Immunocompromised patients
Immunoglobulin
impair
lymphopenia
majority
management
mRNA-based vaccine
mRNA-based vaccine plasma
mutation rate
Patient
patients treated
plasma
receiving
SARS-CoV-2
SARS-CoV-2 viral load
SARS-CoV-2-specific antibodies
severity
spike mutations
survival
therapy
titre
viral control
viral evolution
virus clearance
WHO
whole-genome sequencing
Whole-genome sequencing.
World Health Organization
[DOI] 10.1111/bjh.18450 PMC 바로가기
[DOI] 10.1111/bjh.18450 PMC 바로가기
Artificial Cell Membrane Polymersome-Based Intranasal Beta Spike Formulation as a Second Generation Covid-19 Vaccine
Article
[키워드] ACM
acute respiratory syndrome
adverse effect
airway
antibodies
antibody
antigen presenting cells
artificial
Beta
Beta spike
C57BL/6
cell membrane
clinical symptom
clinical trial
component
conditions
coronavirus
coronavirus disease
COVID-19
CpG
cross-neutralizing
current
delivery of cargo
dendritic cells
dose
doses
evaluate
evaluated
Formulation
generate
Generation
Good
hamster
hamsters
immune responses
immunization
immunogenic
induce
Infection
initiated
interval
intranasal
mice
neutralize
neutralizing antibody
neutralizing responses
New
omicron
Phase 1
polymersome
Practice
PROTECT
reduction
repeated
Safety
SARS-CoV-2
second
serum IgG
spike
Spike protein
Spike-based vaccine
Support
Toxicity
upper respiratory tract
Vaccine
vaccine.
variants
viral clearance
Viral load
virus
weight loss
wild type
[DOI] 10.1021/acsnano.2c06350 PMC 바로가기
[DOI] 10.1021/acsnano.2c06350 PMC 바로가기
Environmental Impacts on COVID-19: Mechanisms of Increased Susceptibility
Article
[키워드] acute respiratory syndrome
addition
age
Air pollution
antioxidant
benefit
boost
caused
changes in
children
clinical symptom
combating
coronavirus
COVID
COVID 19
COVID-19
COVID-19 susceptibility
death
described
disease
Diseases
Environment
Epidemiology
exposure to
free radical
Health
host immunity
host susceptibility
Impact
Increased
induce
Inflammatory cytokine storm
inhibit
Initially
International
involved
knowledge
less
mechanism
morbidity and mortality
outcomes
oxidative stress
pediatric
Preliminary data
reduce
respiratory tract
respiratory viral infections
respiratory viral infections.
SARS-CoV-2
SARS-COV-2 infection
severe COVID-19
severe disease
severity
severity of COVID-19
shown
susceptibility
susceptible
the disease
Vaccine
variant
viral genome
viral infections
viral pathogenicity
while
[DOI] 10.5334/aogh.3907 PMC 바로가기
[DOI] 10.5334/aogh.3907 PMC 바로가기
Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy
Article
[키워드] Activation
age
anti-SARS-CoV-2 antibody
Biomarkers
Blood
blood endothelium
cardiovascular disease
caused
CCP
CCP therapy
Characteristics
characterized
clinical symptom
Concentration
consequence
convalescent plasma
Convalescent plasma therapy
coronavirus disease
COVID-19
death
Donor
downregulation
Endothelial cell
Endothelial dysfunction
Endothelium
evidenced
excessive inflammation
expected
extracellular vesicle
Extracellular vesicles
extracellular vesicles.
hospital
ICAM1
identify
individual
infected individual
inflammatory storm
massive secretion
mechanism
mild symptoms
mitochondrial dysfunction
multi-organ failure
onset of symptom
overexpression
parameter
Peripheral blood
plasma
Potential
pro-inflammatory
pro-inflammatory cytokine
progression
promoted
reflected
selected
Selection
severity
subset
Symptoms
the disease
therapy
vaccination
Vascular endothelium
vascular inflammation
vessel
was increased
[DOI] 10.3390/cells11193122 PMC 바로가기
[DOI] 10.3390/cells11193122 PMC 바로가기
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods
Article
[키워드] addition
age
Antigen
Asymptomatic
booster
children
clinical symptom
Community
conducted
cough
COVID-19
COVID-19 symptom
COVID-19 testing
cross-sectional
Delta
Duration
Evolution
Fever
first positive
Fisher
Health
Isolation
Latinx
less
loss of taste
median
myalgia
negative test
omicron
outcome
participant
Participants
Patient
Period
population immunity
positive
positive result
positive test result
Practitioner
proportion
public health
Rapid
remained
repeated
reported
reported symptoms
San Francisco
SARS-COV-2 infection
seeking
Site
sore throat
Symptom
symptom onset
symptomatic
symptomatic participant
Symptoms
Test
tested
Testing
upper respiratory tract
vaccination
Vaccine
variant
Viral variants
were used
with COVID-19
worsening
χ2 test
[DOI] 10.1001/jamanetworkopen.2022.35844 PMC 바로가기
[DOI] 10.1001/jamanetworkopen.2022.35844 PMC 바로가기
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial
Randomized Controlled Trial
[키워드] absence
Administered
analysed
Anti-spike
clinical
clinical symptom
clinical trial
co-morbidity
Community
Course
COVID-19
COVID-19 pandemic
double blind
Effect
Efficacy and safety
eligibility criteria
evaluate
Evaluating
healthcare
Immunoglobulin
Infection
nasal
offer
participant
Placebo
placebo-controlled
placebo-controlled trial
positive
primary end point
Prophylactic
Prophylaxis
random
randomised
Randomised trial
Randomized
reduced
Result
Safe
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2.
significantly
subject
tested
the primary endpoint
the spike protein
Treatment
vaccination
[DOI] 10.1016/j.jcv.2022.105248 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1016/j.jcv.2022.105248 PMC 바로가기 [Article Type] Randomized Controlled Trial